Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153
- Limin Niu 1, Weicheng Zhou 2, Xiao Li 1, Jinming Zhao 1, Lei Li 1, Xingguo Song 3
- Limin Niu 1, Weicheng Zhou 2, Xiao Li 1
- 1Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China.
- 2Core & Molecular Lab (CML), Roche Diagnostics (Shanghai) Limited, Shanghai, PR China.
- 3Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China. xgsong@sdfmu.edu.cn.
- 0Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Circulating PIWI-interacting RNAs (piRNAs) show promise for early breast cancer detection. A machine learning model combining a tri-piRNA signature with CA153 achieved superior diagnostic accuracy.
Area Of Science
- Molecular Biology
- Oncology
- Bioinformatics
Background
- PIWI-interacting RNAs (piRNAs) play roles in cancer development.
- Circulating piRNAs are potential biomarkers for cancer detection.
Purpose Of The Study
- To investigate the diagnostic utility of circulating piRNAs for breast cancer (BC).
- To develop and validate machine learning (ML) models for early BC diagnosis using piRNA signatures and clinical factors.
Main Methods
- Serum piRNA sequencing identified a tri-piRNA signature (piR-139966, piR-2572505, piR-2570061).
- Quantitative PCR (qPCR) validated piRNA expression levels.
- Machine learning algorithms were employed to build predictive models integrating piRNA data with CA153 levels.
Main Results
- The identified tri-piRNA signature was significantly upregulated in early-stage BC patients.
- The piRNA panel enhanced diagnostic precision for BC detection, complementing CA153.
- An XGBoost-based ML model integrating piRNA expression and CA153 demonstrated optimal performance for early BC identification.
Conclusions
- Circulating piRNAs represent a promising biomarker for non-invasive early breast cancer diagnosis.
- Machine learning frameworks can effectively integrate multi-modal data (piRNAs and CA153) for improved BC diagnostic accuracy.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:57
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
02:39
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

